Plasma MicroRNA Profiling of Plasmodium falciparum Biomass and Association with Severity of Malaria Disease.

Mozambique Plasmodium falciparum Spain biomarkers histidine-rich protein 2 malaria miRNA next-generation sequencing parasites severe malaria vector-borne infections

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
02 2021
Historique:
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Severe malaria (SM) is a major public health problem in malaria-endemic countries. Sequestration of Plasmodium falciparum-infected erythrocytes in vital organs and the associated inflammation leads to organ dysfunction. MicroRNAs (miRNAs), which are rapidly released from damaged tissues into the host fluids, constitute a promising biomarker for the prognosis of SM. We applied next-generation sequencing to evaluate the differential expression of miRNAs in SM and in uncomplicated malaria (UM) in children in Mozambique. Six miRNAs were associated with in vitro P. falciparum cytoadhesion, severity in children, and P. falciparum biomass. Relative expression of hsa-miR-4497 quantified by TaqMan-quantitative reverse transcription PCR was higher in plasma of children with SM than those with UM (p<0.048) and again correlated with P. falciparum biomass (p = 0.033). These findings suggest that different physiopathological processes in SM and UM lead to differential expression of miRNAs and suggest a pathway for assessing their prognostic value malaria.

Identifiants

pubmed: 33496227
doi: 10.3201/eid2702.191795
pmc: PMC7853565
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

430-442

Références

Malar J. 2016 Mar 15;15:167
pubmed: 26979504
PLoS Negl Trop Dis. 2017 Apr 6;11(4):e0005365
pubmed: 28384192
J Mol Diagn. 2013 Nov;15(6):827-34
pubmed: 23988620
Nucleic Acids Res. 2016 May 5;44(8):3865-77
pubmed: 26921406
Malar J. 2008 Mar 10;7:47
pubmed: 18328111
Cancer Prev Res (Phila). 2009 Sep;2(9):807-13
pubmed: 19723895
Immunol Rev. 2020 Jan;293(1):230-252
pubmed: 31562653
Brief Bioinform. 2016 Mar;17(2):204-12
pubmed: 26238539
J Infect Dis. 2013 Jul 15;208(2):192-8
pubmed: 23585685
Cell Host Microbe. 2012 Aug 16;12(2):187-99
pubmed: 22901539
J Affect Disord. 2016 Aug;200:250-8
pubmed: 27152760
PLoS Med. 2005 Aug;2(8):e204
pubmed: 16104831
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
pubmed: 18663219
Nature. 2013 Jun 27;498(7455):502-5
pubmed: 23739325
Am J Trop Med Hyg. 1992 Aug;47(2):259-64
pubmed: 1503193
BMC Mol Biol. 2016 Feb 09;17:4
pubmed: 26860190
PLoS One. 2011 Apr 29;6(4):e19422
pubmed: 21559373
Trends Parasitol. 2011 Nov;27(11):481-6
pubmed: 21840260
PLoS One. 2018 Mar 5;13(3):e0193527
pubmed: 29505615
Malar J. 2009 Jan 09;8:9
pubmed: 19134201
Dis Markers. 2011;31(6):327-35
pubmed: 22182805
PLoS Med. 2012;9(8):e1001297
pubmed: 22927801
Auris Nasus Larynx. 2019 Feb;46(1):106-113
pubmed: 29843929
Infect Immun. 2011 Jun;79(6):2379-84
pubmed: 21422175
Genome Biol. 2014;15(12):550
pubmed: 25516281
Microrna. 2013;2(1):14-9
pubmed: 25070711
J Clin Microbiol. 2014 Jun;52(6):2144-9
pubmed: 24740073
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7620-4
pubmed: 9636199
Nat Rev Clin Oncol. 2011 Jun 07;8(8):467-77
pubmed: 21647195
Nucleic Acids Res. 2010 Mar;38(5):e34
pubmed: 20008100
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
Malar J. 2016 Jun 29;15:337
pubmed: 27357958
PLoS One. 2017 Feb 2;12(2):e0167969
pubmed: 28151938
Front Cell Infect Microbiol. 2014 Aug 21;4:104
pubmed: 25191643
PLoS One. 2008 Jun 04;3(6):e2360
pubmed: 18523662
Bioinformatics. 2011 Nov 15;27(22):3202-3
pubmed: 21976421
Expert Rev Mol Med. 2009 May 26;11:e16
pubmed: 19467172
Tuberculosis (Edinb). 2013 Dec;93 Suppl:S47-50
pubmed: 24388649
Bioinformatics. 2017 May 15;33(10):1554-1560
pubmed: 28108447
Malar J. 2014 Jul 21;13:279
pubmed: 25047113
Nature. 2002 Feb 7;415(6872):673-9
pubmed: 11832955
Front Genet. 2013 May 24;4:94
pubmed: 23745127
Am J Pathol. 2011 May;178(5):2146-58
pubmed: 21514429
FEBS Lett. 2006 Oct 2;580(22):5185-8
pubmed: 16963026
Front Cell Infect Microbiol. 2015 Oct 27;5:75
pubmed: 26579500

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH